A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer

Introduction: This is a retrospective analysis to assess the safety and efficacy of abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC) patients treated at tertiary care institute. Materials and Methods: The clinical records of mCRPC patients treated with AA at our tert...

Full description

Bibliographic Details
Main Authors: Amit Joshi, Sameer Shrirangwar, Vanita Noronha, Nilesh Sable, Archi Agarwal, Palak Popat, Atanu Bhattacharjee, Kumar Prabhash
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:South Asian Journal of Cancer
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/sajc.sajc_433_18